Amlodipine/telmisartan/hydrochlorothiazide - IlDong

Drug Profile

Amlodipine/telmisartan/hydrochlorothiazide - IlDong

Alternative Names: TAH - IlDong Pharmaceutical; Telmisartan/amlodipine besylate/hydrochlorothiazide - IlDong Pharmaceutical

Latest Information Update: 01 Feb 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Il Dong
  • Class Antihypertensives; Benzimidazoles; Benzoates; Benzothiadiazines; Branched-chain amino acids; Dihydropyridines; Small molecules
  • Mechanism of Action Angiotensin type 1 receptor antagonists; Calcium channel antagonists; Thiazide diuretics
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Essential hypertension

Most Recent Events

  • 27 Dec 2016 IlDong Pharmaceutical completes a phase I pharmacokinetics trial in Healthy volunteers in South Korea (PO) (NCT03032315)
  • 01 Aug 2016 IlDong Pharmaceutical completes a phase III trial in Essential hypertension in South Korea (NCT02738632)
  • 22 Jun 2016 Chemical information added
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top